This work may not be copied, distributed, displayed, published, reproduced, transmitted, modified, posted, sold, licensed, or used for commercial purposes. By downloading this file, you are agreeing to the publisher’s Terms & Conditions.


Introduction: Generalized Anxiety Disorder: Why Are We Failing Our Patients?

Philip T. Ninan, MD

Published: January 5, 2001

Article Abstract

Because this piece does not have an abstract, we have provided for your benefit the first 3 sentences of the full text.

Generalized anxiety disorder (GAD) is associated with considerable distress as well as substantial social and functional impairment comparable to or exceeding the level of disability arising from chronic somatic illnesses.1 This supplement examines the current status of knowledge in GAD and explores mechanisms to bring about optimal outcomes. Most randomized, controlled clinical studies that evaluate treatment efficacy do not assess social and occupational function beyond symptomatic improvement. About 50% to 60% of patients respond to antidepressants,2 but only about one third of patients with depression or anxiety achieve remission (i.e., functional normality indistinguishable from that of individuals without illness).2,3

Some JCP and PCC articles are available in PDF format only. Please click the PDF link at the top of this page to access the full text.

Related Articles

Volume: 62

Quick Links: